400 related articles for article (PubMed ID: 29484801)
1. Brain injury markers: S100 calcium-binding protein B, neuron-specific enolase and glial fibrillary acidic protein in children with diabetic ketoacidosis.
Çatlı G; Anık A; Acar S; Küme T; Karabulut M; Çalan ÖG; Dündar BN; Abacı A
Pediatr Diabetes; 2018 Aug; 19(5):1000-1006. PubMed ID: 29484801
[TBL] [Abstract][Full Text] [Related]
2. Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis.
Elshorbagy HH; Barseem NF; Elsadek AE; Al-shokary AH; Maksoud YHA; Abdulsamea SE; Talaat IM; Suliman HA; Kamal NM; Abdelghani WE; Azab SM; El Din DMN
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):374-387. PubMed ID: 31067852
[TBL] [Abstract][Full Text] [Related]
3. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A
Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052
[TBL] [Abstract][Full Text] [Related]
4. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
[TBL] [Abstract][Full Text] [Related]
5. Multiple indicators model of long-term mortality in traumatic brain injury.
Gradisek P; Osredkar J; Korsic M; Kremzar B
Brain Inj; 2012; 26(12):1472-81. PubMed ID: 22721420
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum Neuron-specific enolase, S100B, myelin basic protein and glial fibrilliary acidic protein as brain specific proteins in children with autism spectrum disorder.
Esnafoglu E; Ayyıldız SN; Cırrık S; Erturk EY; Erdil A; Daglı A; Noyan T
Int J Dev Neurosci; 2017 Oct; 61():86-91. PubMed ID: 28711670
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
Park SH; Hwang SK
World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
[TBL] [Abstract][Full Text] [Related]
9. Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
Okonkwo DO; Puffer RC; Puccio AM; Yuh EL; Yue JK; Diaz-Arrastia R; Korley FK; Wang KKW; Sun X; Taylor SR; Mukherjee P; Markowitz AJ; Jain S; Manley GT;
J Neurotrauma; 2020 Dec; 37(23):2460-2467. PubMed ID: 32854584
[TBL] [Abstract][Full Text] [Related]
10. Levels of S100B in brain and blood of rats with diabetic ketoacidosis.
Glaser N; Lo W; Tancredi D; Orgain M; Puvenna V; Janigro D; O Donnell M
Brain Res; 2015 Oct; 1624():536-544. PubMed ID: 26254728
[TBL] [Abstract][Full Text] [Related]
11. Serial measurement of S100B and NSE in pediatric traumatic brain injury.
Park DW; Park SH; Hwang SK
Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330
[TBL] [Abstract][Full Text] [Related]
12. Minor head injury in anticoagulated patients: performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study.
Menditto VG; Moretti M; Babini L; Mattioli A; Giuliani AR; Fratini M; Pallua FY; Andreoli E; Nitti C; Contucci S; Gabrielli A; Rocchi MBL; Pomponio G
Clin Chem Lab Med; 2024 Jun; 62(7):1376-1382. PubMed ID: 38206121
[TBL] [Abstract][Full Text] [Related]
13. Increase of plasma S100B and neuron-specific enolase in children following adenotonsillectomy: a prospective clinical trial.
Stojanovic Stipic S; Carev M; Bajic Z; Supe Domic D; Roje Z; Jukic A; Stipic T
Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3781-3788. PubMed ID: 28785895
[TBL] [Abstract][Full Text] [Related]
14. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of serum glial fibrillary acidic protein and S100B serum levels in emergency medicine patients with traumatic versus nontraumatic intracerebral hemorrhage.
Aydin I; Algin A; Poyraz MK; Yumrutas O
Niger J Clin Pract; 2018 Dec; 21(12):1645-1650. PubMed ID: 30560830
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
Geyer C; Ulrich A; Gräfe G; Stach B; Till H
J Neurosurg Pediatr; 2009 Oct; 4(4):339-44. PubMed ID: 19795965
[TBL] [Abstract][Full Text] [Related]
17. Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.
Ondruschka B; Woydt L; Bernhard M; Franke H; Kirsten H; Löffler S; Pohlers D; Hammer N; Dreßler J
Int J Legal Med; 2019 May; 133(3):871-881. PubMed ID: 30167776
[TBL] [Abstract][Full Text] [Related]
18. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.
Vos PE; van Gils M; Beems T; Zimmerman C; Verbeek MM
Eur J Neurol; 2006 Jun; 13(6):632-8. PubMed ID: 16796588
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis.
Rohlwink UK; Mauff K; Wilkinson KA; Enslin N; Wegoye E; Wilkinson RJ; Figaji AA
Clin Infect Dis; 2017 Oct; 65(8):1298-1307. PubMed ID: 28605426
[TBL] [Abstract][Full Text] [Related]
20. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
